Fatima Laher to Vaccines, Combined
This is a "connection" page, showing publications Fatima Laher has written about Vaccines, Combined.
Connection Strength
0,058
-
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial. PLoS Med. 2024 Mar; 21(3):e1004360.
Score: 0,058